Since the 1990s, the impact of genetic testing for insurance has been the subject of international debates. However, these have been rather speculative and abstract. In an effort to find new openings, the author explores this concern from an empirical sociological angle - by studying the...

The emergence of a global industry of digital health platforms operated by Big Tech corporations, and its growing entanglements with academic and pharmaceutical research networks, have raised increasingly pressing questions on the capacity of current data governance models, regulatory and legal...

Rapid proliferation of medical innovations in the face of demographic changes and scarce resources is demanding a value-conscious entry of medical innovations into health care systems. An inquiry into value gains significance during the early diffusion phase of an innovation and becomes...